• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

PDS Biotechnology Corp (PDSB)

Common Shares
Sell: $0.8021|Buy: $0.815|Change: 0.01 (-1.14%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Address

300 Connell Drive
Suite 4000
Berkeley Heights
NJ
USA
07922

Website

https://www.pdsbiotech.com

Sector 

Healthcare

Forecast key dates

NameKey Date
PDS Biotechnology Corp Third Quarter Earnings Conference Call for 20262026-11-13T08:00:00
PDS Biotechnology Corp Third Quarter Earnings Results for 20262026-11-13T00:00:00
PDS Biotechnology Corp Second Quarter Earnings Conference Call for 20262026-08-13T08:00:00
PDS Biotechnology Corp Second Quarter Earnings Results for 20262026-08-13T00:00:00
PDS Biotechnology Corp Annual General Meeting for 20262026-06-11T08:00:00
PDS Biotechnology Corp First Quarter Earnings Conference Call for 20262026-05-14T08:00:00
PDS Biotechnology Corp First Quarter Earnings Results for 20262026-05-14T00:00:00
PDS Biotechnology Corp Fourth Quarter Earnings Conference Call for 20252026-03-27T08:00:00
PDS Biotechnology Corp Fourth Quarter Earnings Results for 20252026-03-27T00:00:00
PDS Biotechnology Corp Annual Report for 20252026-03-27T00:00:00

Previous key dates

NameKey Date
PDS Biotechnology Corp Third Quarter Earnings Conference Call for 20252025-11-13T08:00:00
PDS Biotechnology Corp Third Quarter Earnings Results for 20252025-11-13T00:00:00
PDS Biotechnology Corp Second Quarter Earnings Conference Call for 20252025-08-13T08:00:00
PDS Biotechnology Corp Second Quarter Earnings Result for 20252025-08-13T00:00:00
PDS Biotechnology Corp Annual General Meeting for 20252025-06-11T08:00:00
ASCO Abstract Data Sets2025-05-23T08:00:00
A.G.P. Virtual Annual Healthcare Company Showcase2025-05-21T17:20:00
PDS Biotechnology Corp First Quarter Earnings Conference Call for 20252025-05-14T08:00:00
PDS Biotechnology Corp First Quarter Earnings Result for 20252025-05-14T00:00:00
2025 CAGLA NeauxCancer Conference2025-03-28T16:00:00
PDS Biotechnology Corp Fourth Quarter Earnings Conference Call for 20242025-03-27T08:00:00
PDS Biotechnology Corp Fourth Quarter Earnings Result for 20242025-03-27T00:00:00
PDS Biotechnology Corp Annual Report for 20242025-03-27T00:00:00
Zacks SCR Life Sciences Virtual Investor Forum2025-03-13T14:30:00
B. Riley Securities Precision Oncology & Radiopharma Conference 20252025-02-28T11:30:00
PDS Biotechnology Virtual KOL Event2024-12-17T12:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.